Life Technologies (Thermo Fisher Scientific)
Life Technologies ( NASDAQ: LIFE) is one of the world's largest biotechnology company based in Carlsbad, California, United States of America., 2011, Life about 10,400 people and generated sales of 3.7 billion U.S. dollars. Life holds more than 4,000 patents and licenses, offering over 50,000 products on the market for medical and basic research on.
Brands
Applied Biosystems provides research equipment for genotyping, genetic and forensic DNA analysis, food testing, animal health, pharmaceutical purification and analysis, PCR, influenza research, stem cell research and laser microdissection.
Ambion is the key brand of Life for RNA-based research. Ambion offers products for isolation, detection, quantification, amplification and characterization of RNA ( from bacteria, tissues, cells, yeast, blood etc ). In addition, synthesized RNA is offered.
Gibco produced materials and solutions for the cell culture.
Invitrogen is the key brand of Life for molecular biology applications based on DNA ( genomic, drug, proteomics, cellular analysis).
Molecular Probes offers products for fluorescent labeling and detection of cell biology, nanotechnology and antibody laboratories.
Novex is the key brand of protein research and offers products to Purifizierung, isolation, quantification and analysis of proteins (SDS -PAGE, antibody technology, Western blot).
TaqMan provides research products for gene expression ( RT- PCR) miRNA, protein analysis, SNP genotyping.
Ion Torrent is the first commercial provider of Ion semiconductor sequencing DNA systems.
Company History
Life Technologies Inc., was a subsidiary of Dexter Corp.. 1983 by the merger of Bethesda Research Laboratories Inc. and GIBCO Corp.. ( Grand Iceland Biological Company) was founded. In 2000 the company was purchased by the smaller but well-funded Invitrogen, Life Technologies, the related name later for the entire Group.
Life Technologies Incorporated was formed on 21 November 2008 by the merger of Invitrogen and Applied Biosystems.
On 1 July 2012, the Company announced that it takes over the company Navigenics and thus expands in the field of molecular diagnostics.